TCIM
EGRX

TIAA CREF Investment Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

TIAA CREF Investment Management’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$967K Sell
19,159
-9,080
-32% -$404K ﹤0.01% 2332
2018
Q4 		$1.14M Sell
28,239
-83
-0.3% -$4.28K ﹤0.01% 2233
2018
Q3 		$1.96M Buy
28,322
+6,286
+29% +$477K ﹤0.01% 2125
2018
Q2 		$1.67M Buy
22,036
+1,740
+9% +$109K ﹤0.01% 2270
2018
Q1 		$1.07M Hold
20,296
– – ﹤0.01% 2408
2017
Q4 		$1.08M Sell
20,296
-2,614
-11% -$145K ﹤0.01% 2424
2017
Q3 		$1.37M Buy
22,910
+176
+0.8% +$10.6K ﹤0.01% 2366
2017
Q2 		$1.79M Sell
22,734
-1,376
-6% -$113K ﹤0.01% 2243
2017
Q1 		$2M Sell
24,110
-1,516
-6% -$113K ﹤0.01% 2144
2016
Q4 		$2.03M Sell
25,626
-549
-2% -$39.9K ﹤0.01% 2181
2016
Q3 		$1.83K Sell
26,175
-152
-0.6% -$8.42K ﹤0.01% 2227
2016
Q2 		$1.02M Sell
26,327
-107
-0.4% -$4.46K ﹤0.01% 2500
2016
Q1 		$1.07M Sell
26,434
-3,493
-12% -$222K ﹤0.01% 2430
2015
Q4 		$2.65M Sell
29,927
-801
-3% -$63.2K ﹤0.01% 1992
2015
Q3 		$2.27M Sell
30,728
-1,204
-4% -$100K ﹤0.01% 2058
2015
Q2 		$2.58M Buy
+31,932
New +$2.08M ﹤0.01% 2137

Other funds holding EGRX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

TIAA CREF Investment Management's EGRX Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Eagle Pharmaceuticals, Inc. (EGRX) stake by 32% in Q1 2019, selling an estimated $404K and leaving 19,159 shares worth $967K. The position accounts for ﹤0.01% of the portfolio, ranked #2332.

TIAA CREF Investment Management first reported a position in EGRX in Q2 2015 and has held it in 16 quarters since. The position peaked at $2.65M in Q4 2015. 182 funds tracked by Wall St. Rank hold EGRX as of Q1 2019.

  • TIAA CREF Investment Management held 19,159 shares of Eagle Pharmaceuticals, Inc. worth $967K as of Q1 2019.
  • TIAA CREF Investment Management sold 9,080 Eagle Pharmaceuticals, Inc. shares in Q1 2019, an estimated $404K.
  • Eagle Pharmaceuticals, Inc. made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2332 holding.
  • TIAA CREF Investment Management first reported a position in Eagle Pharmaceuticals, Inc. in Q2 2015 and has held it in 16 quarters since.
  • TIAA CREF Investment Management's Eagle Pharmaceuticals, Inc. position peaked at $2.65M in Q4 2015.
  • 182 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.